Crossref
CD36 promotes chemotherapy resistance and stemness of cervical cancer cells through the Hippo and ERK5 pathway activation
International Journal of Clinical and Experimental Medicine · 2025
DOI: 10.62347/hftc6895 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Medicine, 2025. Verfasst von Lin-Ying Xie. Die Arbeit nennt 41 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Xie, L. (2025). CD36 promotes chemotherapy resistance and stemness of cervical cancer cells through the Hippo and ERK5 pathway activation. International Journal of Clinical and Experimental Medicine. https://doi.org/10.62347/hftc6895
Vancouver
Xie L. CD36 promotes chemotherapy resistance and stemness of cervical cancer cells through the Hippo and ERK5 pathway activation. International Journal of Clinical and Experimental Medicine. 2025. doi:10.62347/hftc6895
BibTeX
@article{Xie2025,
author = {Xie, Lin-Ying},
title = {CD36 promotes chemotherapy resistance and stemness of cervical cancer cells through the Hippo and ERK5 pathway activation},
journal = {International Journal of Clinical and Experimental Medicine},
year = {2025},
doi = {10.62347/hftc6895}
}
EUVIMED